Sarcoma  >>  evofosfamide (IMGS-101)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
evofosfamide (IMGS-101) / Molecular Templates, ImmunoGenesis
TH-CR-406, NCT01440088 / 2011-003145-17: A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

Completed
3
640
US, Canada, Europe, RoW
TH-302 in Combination with Doxorubicin, Doxorubicin
Threshold Pharmaceuticals, Sarcoma Alliance for Research through Collaboration (SARC)
Soft Tissue Sarcoma
12/15
05/16

Download Options